About Journal of Nanotheranostics

Aims

The Journal of Nanotheranostics (JNT) (ISSN 2624-845X) is a peer-reviewed multidisciplinary open access platform at the intersection of nanotechnology and therapeutics/diagnostics. At its core, nanotheranostics represents the convergence of nanotechnology, molecular diagnostics and targeted therapies, transforming patient care by utilizing disease detection and precision treatment into a single workflow.

We serve as a premier forum for engineers, scientists and clinicians developing next-generation nanotheranostics. The journal publishes topical reviews, perspectives and opinion articles as well as exciting fundamental and translational research articles in the form of brief reports and full papers. Brief reports are reserved for the rapid dissemination of novel findings at an early stage of an investigation that carry wide-ranging implications for the journal’s audience. They do not need to be full or extensive studies.

JNT has no restrictions on the length of papers with exception of opinion articles and brief reports, which must not exceed 4 printed pages. Authors are encouraged to provide sufficient detail to ensure transparency, reproducibility and a clear presentation of their work while maintaining clarity and conciseness.

Scope

Our scope encompasses the design, synthesis and biological evaluation (in vitro and in vivo) of multifunctional nanoparticles, nanoscale devices and smart biomaterials that integrate advanced diagnostic and therapeutic modalities. We welcome submissions that cover, but are not limited to, the following:

• Nanomaterial advances in theranostic/radiotheranostic applications;
• Biophotonics and multimodal molecular imaging to track, visualize and quantify targeted drug delivery systems in real time;
• Engineering of smart nanoplatforms that interface directly with point-of-care devices for rapid theranostic workflow, including the use of biophotonics in lab-on-a-chip technologies;
• Structure-activity studies that map how design changes govern cellular entry, tissue distribution and performance of nanotheranostic platforms;
• Biocompatibility and safety profiling of nanotheranostic systems;
• Machine learning and artificial intelligence approaches aiding nanotheranostic platform design and performance;
• Regulatory, practice and environmental issues pertaining to nanotheranostics.

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in JNT will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact publisher@mdpi.com for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is nanotheranostics@mdpi.com.

Editorial Office

For further MDPI contacts, see here.